DP3
DP3 (DP3) is a company in Vietnam's Health Care sector, listed on HNX. The stock last traded at 60,700 VND, little changed on the session, giving a market capitalization of 1.4 trillion VND.
On valuation, DP3 trades at a price-to-earnings ratio of 7.4 and a price-to-book of 2.1. That is a discount to the Health Care sector average P/E of 18.9. Return on equity of 29.1% points to strong profitability relative to the company's equity base, above the sector average of 11.5%. Trailing earnings per share stand at 8,091 VND.
Aveluro tracks 1 news item mentioning DP3, where recent coverage skews positive (100% of articles). The most recent catalyst was an earnings beat event — "DP3 Foripharm beats full-year profit plan in H1 2026, revenue up 41%". Aveluro's composite model rates DP3 7.1/10 (Bullish), blending news sentiment, price momentum, and fundamentals.
Comparable names in the Health Care sector include AGP, AMP and AMV.
DP3 Foripharm beats full-year profit plan in H1 2026, revenue up 41%
By Aveluro Research Team · Editorial policy · Caveat: Not investment advice. · How Aveluro computed this